Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
Public ClinicalTrials.gov record NCT02995733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations
Study identification
- NCT ID
- NCT02995733
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Enrollment
- 1,220 participants
Conditions and interventions
Conditions
Interventions
- PARTICS using QVAR Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 26, 2017
- Primary completion
- Apr 29, 2021
- Completion
- Apr 29, 2021
- Last update posted
- Jan 18, 2023
2017 – 2021
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35294 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Denver Health and Hospital Authority | Denver | Colorado | 80209 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Grace Medical Home | Orlando | Florida | 32827 | — |
| University of Central Florida | Orlando | Florida | 32827 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| University of Illinois- Chicago | Chicago | Illinois | 60607 | — |
| Baystate Health Center | Springfield | Massachusetts | 01199 | — |
| Mt. Sinai | New York | New York | 10029 | — |
| Montefiore | The Bronx | New York | 10461 | — |
| University of North Carolina | Chapel Hill | North Carolina | 25799 | — |
| Atrium Health | Charlotte | North Carolina | 28207 | — |
| Duke University | Durham | North Carolina | 27705 | — |
| MetroHealth | Cleveland | Ohio | 44109 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Temple University | Philadelphia | Pennsylvania | 19122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02995733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2023 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02995733 live on ClinicalTrials.gov.